ArticleClinical case reports2021

Early complete response of primary bone marrow B-cell lymphoma treated with rituximab-based CHOP therapy, assessed by flow cytometry and immunogloblin heavy chain rearrangement.

Yoshimi Nabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.